FDA Medical Device Establishment Registration and Device Listing
Companies planning to manufacture, import, distribute, or commercialize medical devices in the United States need to understand the difference between FDA establishment registration, device listing, and premarket authorization.
Under the U.S. regulatory framework, establishments involved in the production and distribution of medical devices intended for commercial distribution generally have registration and listing obligations under 21 CFR Part 807. The specific requirement depends on the type of establishment and activity performed.
It is also important to understand that FDA establishment registration and device listing do not mean that FDA has approved or cleared the establishment or its products. FDA’s public registration database specifically states that registration or listing should not be interpreted as FDA approval.
Regulatory Excellence for Global Medical Device Markets
What Is FDA Establishment Registration?
FDA establishment registration is the process through which a medical device establishment provides required information to the FDA about its business and activities.
Establishments involved in manufacturing, processing, importing, repackaging, relabeling, sterilizing, or other regulated activities may have registration obligations depending on their specific role.
For example, FDA identifies foreign manufacturers, contract manufacturers, contract sterilizers, foreign exporters, initial importers, specification developers, repackers, relabelers, and certain other establishments among those that may be required to register.
The registration process is completed electronically through the FDA’s FURLS/Device Registration and Listing Module (DRLM).
What Is FDA Device Listing?
FDA device listing is the process of providing information about the medical devices manufactured, processed, or handled by an establishment.
Most establishments that are required to register are also required to list the devices and identify the activities performed on those devices. When a device requires premarket authorization, the applicable premarket submission number, such as a 510(k), De Novo, PMA, PDP, or HDE, may need to be provided.
Device listing is therefore connected to establishment registration, but the two are not the same process.
FDA Registration vs Device Listing
| FDA requirement | What it means |
|---|---|
| Establishment registration | Identifies the establishment and its regulated activities |
| Device listing | Identifies the medical devices and relevant activities |
| Premarket submission | Provides the applicable regulatory pathway for devices requiring premarket review |
| U.S. Agent | Required for foreign establishments subject to FDA registration |
This distinction is important because FDA registration is not the same as FDA approval.
Who Needs FDA Medical Device Establishment Registration?
The requirement depends on the establishment’s activity.
FDA generally requires establishments involved in the production and distribution of medical devices intended for commercial distribution in the United States to register annually. Most establishments required to register must also list their devices.
Examples can include:
- Medical device manufacturers
- Foreign manufacturers
- Contract manufacturers
- Contract sterilizers
- Foreign exporters
- Repackers and relabelers
- Specification developers
- Initial importers
- Certain manufacturers of accessories and components
However, not every establishment involved in the medical device supply chain has identical registration and listing obligations. The applicable requirement should be determined based on the actual activity performed by the company.
Schedule a Compliance Consultation
Accelerate Market Access with End-to-End Regulatory Guidance
Do Initial Importers Need to List Devices?
An initial importer has a specific role under FDA’s medical device regulations.
FDA defines an initial importer as an importer that furthers the marketing of a device from a foreign manufacturer to the person making the final delivery or sale to the ultimate consumer or user, without repackaging or otherwise changing the container, wrapper, or labeling.
Initial importers generally have an establishment registration requirement, but FDA guidance indicates that an initial importer does not list the devices it imports in the same way as establishments that manufacture or otherwise perform specified activities on those devices.
Understanding the difference between a foreign manufacturer, foreign exporter, and initial importer is therefore important when setting up a U.S. market-entry strategy.
U.S. Agent Requirements for Foreign Medical Device Manufacturers
Foreign medical device establishments that are required to register must identify a U.S. Agent.
The U.S. Agent serves as a point of contact between the foreign establishment and FDA and has responsibilities under FDA’s regulatory framework.
Foreign manufacturers should therefore establish the appropriate U.S. Agent arrangement before beginning the U.S. import and commercialization process.
FDA’s 2026 regulatory guidance confirms that foreign establishments must register, list, and identify a U.S. Agent before exporting applicable medical devices to the United States.
FDA Medical Device Establishment Registration Process
The FDA establishment registration process involves several key steps.
1. Determine the Establishment Type
First, identify the activities performed by the company and determine whether FDA registration and listing requirements apply.
2. Determine Device Listing Requirements
Identify the devices associated with the establishment and determine whether they need to be listed.
3. Determine the Premarket Pathway
If the device requires premarket authorization, identify the applicable pathway, such as 510(k), De Novo, PMA, PDP, or HDE.
FDA states that the applicable premarket submission number should be provided when a device requires premarket review.
4. Pay the FDA Establishment Registration Fee
Most establishments subject to registration must pay the applicable FDA establishment registration fee before completing registration.
For FY 2026, the annual establishment registration fee is $11,423. For FY 2027, FDA has announced an annual fee of $13,785. These fees apply to the relevant fiscal years and should be verified with FDA before payment.
FDA also provides a Small Business Determination program under which certain qualifying small businesses may receive a waiver of the annual establishment registration fee, excluding the initial registration fee.
5. Obtain the Payment Information
After payment through the Device Facility User Fee system, the establishment receives a Payment Identification Number (PIN) and, after payment processing, a Payment Confirmation Number (PCN).
The FDA states that these details are required when completing the registration through FURLS/DRLM.
6. Submit Registration and Listing Information
The establishment then submits its registration and applicable device listing information electronically through FURLS/DRLM.
7. Review the Submitted Information
Companies should carefully review establishment details, device information, manufacturer information, U.S. Agent information, and other regulatory data before submitting the registration.
When Should FDA Registration Be Completed?
For initial registration, FDA requires applicable establishments to submit registration and/or listing information within the required timeframe.
FDA states that initial registration and listing should generally be submitted within 30 days of an establishment beginning a regulated activity or placing a device into commercial distribution. Foreign establishments have additional timing requirements related to exporting to the United States.
After initial registration, establishments subject to annual registration must review and submit their registration information between October 1 and December 31 each year. Device listing information should also be reviewed during this period.
What Information Is Required for FDA Device Listing?
The information required can vary depending on the establishment and device.
Companies may need to provide information such as:
- Establishment details
- Establishment type
- Manufacturer information
- Device name
- Product code
- Proprietary or trade name
- Listing information
- Premarket submission number, when applicable
- Activities performed on the device
- U.S. Agent information for applicable foreign establishments
The information submitted should remain consistent with the company’s regulatory and product documentation.
FDA Establishment Registration vs FDA Approval
One of the most important concepts for medical device companies is that FDA establishment registration is not FDA approval.
Registration tells FDA that a qualifying establishment is registered and identifies its activities. Device listing provides information about devices associated with that establishment.
Depending on the device, a separate premarket pathway may be required, such as:
- 510(k) Premarket Notification
- De Novo Classification Request
- Premarket Approval (PMA)
- Humanitarian Device Exemption (HDE)
FDA determines the applicable pathway based on the device and its regulatory classification.
Companies should therefore establish the correct regulatory pathway before assuming that registration and listing alone authorize a device for U.S. commercial distribution.
How Operon Strategist Can Help
Navigating FDA medical device establishment registration and device listing can be challenging, particularly for foreign manufacturers entering the U.S. market for the first time.
Operon Strategist supports medical device companies with U.S. FDA regulatory consulting, establishment registration, device listing, regulatory strategy, QMS implementation, 510(k) support, and market-entry requirements.
Our US FDA 510(k) and QMSR registration services can support companies that need assistance with FDA regulatory pathways and quality system requirements.
For companies preparing a 510(k), our guide on FDA 510(k) submission provides additional information about preparing a successful submission.
Companies can also review our FDA eSTAR submission guide to understand the electronic submission approach for applicable 510(k) submissions.
From regulatory strategy and documentation to registration and market entry, Operon Strategist helps medical device companies navigate U.S. regulatory requirements with a structured approach.
Ensure Seamless Regulatory Compliance for Your Device
Get Your Medical Device Market-Ready with Expert Regulatory Support
FAQ's
What is a Medical Device Park?
A dedicated zone with shared infrastructure for medical device manufacturing.Â
What are the benefits?
Lower cost, faster setup, shared facilities, and easier compliance.Â
Is CDSCO approval required?
Yes, it is mandatory for manufacturing and selling medical devices in India.Â
Which are the top parks?
AMTZ, Telangana, Tamil Nadu, and YEIDA are leading parks.
Which are the top parks?
AMTZ, Telangana, Tamil Nadu, and YEIDA are leading parks.